What is a med spa worth?
A med spa (medspa) typically sells for 3x to 6x EBITDA when it is small (typically under $5M of revenue) and 5x to 8x at $5M to $20M of revenue, according to Scope Research's 2026 med spa update. Regional chains above $20M of revenue reach 7x to 12x, and high-growth national platforms 10x to 20x. Buyers pay more for repeat-client revenue, a recognized brand and scale, and less for a spa that depends on its owner.
Want this answered for your own clinic?
Definition
A med spa valuation is the enterprise value buyers assign to a medical aesthetic practice — calculated as a multiple of normalized EBITDA (or seller's discretionary earnings for sub-scale practices), adjusted for membership recurring revenue, provider concentration, and growth.
The detail
Med spa (medspa) valuations span a wide range, and the published bands come from Scope Research, which tracks the deals. Its 2026 update sets four tiers. Small med spas, typically under $5M of revenue, "usually sell for lower multiples, ranging from 3x to 6x EBITDA," which Scope puts down to operational risk, limited reach and heavy reliance on the owner-operator; it says its database of active and recently listed med spas supports that range. Mid-sized spas at $5M to $20M of revenue fetch 5x to 8x. Large regional chains above $20M reach 7x to 12x, and high-growth, tech-driven brands and national platforms 10x to 20x, though Scope says the 20x prints likely include payment for locations still opening and the full-year effect of recent acquisitions. For scale, AmSpa's 2024 State of the Industry report puts average annual med spa revenue at $1,398,833, well inside Scope's bottom tier. The buyer pool is still young: Scope says only 3% of med spas are owned by private equity firms or PE-backed organizations, while announced deals rose from a small handful in 2019 and 2020 to over 40 in each of the past three years. What lifts a multiple, in Scope's list, is brand and customer loyalty, geographic reach, newer technology, a high share of repeat customers and high operating margins. The repeat-customer point has numbers behind it: software vendor CorralData's H1 2026 benchmark of 100+ aesthetics brands found members spend 2.5 times what non-members spend and retain 35 percentage points better at the median, with median membership penetration at 18% of active clients. Injectables were 42.5% of revenue at the median brand. What pulls a multiple down is dependence on the owner-operator, and ownership rules: corporate practice of medicine laws in many states stop non-healthcare providers from owning a med spa directly, so buyers use a management services organization structure. The other half of the exit-prep job is the cost side, since a buyer prices the margin they inherit. Our breakdown of where med spa margin actually leaks covers the four line items that most often explain the gap.
| Operator profile | Published multiple | Source |
|---|---|---|
| Small med spa (typically under $5M revenue) | 3x – 6x EBITDA | Scope Research (2026) |
| Mid-sized med spa (typically $5M–$20M revenue) | 5x – 8x EBITDA | Scope Research (2026) |
| Large, established regional chain (over $20M revenue) | 7x – 12x EBITDA | Scope Research (2026) |
| High-growth, tech-driven brand or national platform | 10x – 20x EBITDA | Scope Research (2026) |
No index publishes med spa transaction multiples; every row is Scope Research's published range. Scope says its database of active and recently listed med spas supports the small-spa range, and that 20x prints likely include payment for locations still opening and the full-year effect of recent acquisitions. For reference, AmSpa's 2024 report puts average med spa revenue at $1,398,833, inside the small-spa tier.
Scope Research's 2026 update: small med spas (typically under $5M of revenue) at 3x to 6x EBITDA, mid-sized ($5M to $20M) at 5x to 8x, large regional chains (over $20M) at 7x to 12x, and high-growth national platforms at 10x to 20x.
Source: Scope Research: Med Spa and Aesthetics Valuation Multiples and M&A Trends 2026
Only 3% of med spas are owned by private equity firms or PE-backed organizations; announced deals rose from a small handful in 2019 and 2020 to over 40 in each of the past three years.
Source: Scope Research: Med Spa and Aesthetics Valuation Multiples and M&A Trends 2026
AmSpa's 2024 State of the Industry report puts average annual med spa revenue at $1,398,833, up from $1,307,587, and counts 10,488 med spas in 2023, up from 8,899 in 2022.
Source: AmSpa: 2024 Medical Spa State of the Industry executive report recap
Members spend 2.5 times what non-members spend and retain 35 percentage points better at the median; median membership penetration is 18% of active clients.
Source: CorralData Research: The State of Aesthetics H1 2026 (100+ aesthetics brands)
Injectables are 42.5% of revenue at the median brand in CorralData's H1 2026 cohort.
Source: CorralData Research: The State of Aesthetics H1 2026 (100+ aesthetics brands)
What this means for clinic owners
From Sorso
Owner dependence is the discount Scope names first: its small-spa range is low partly because the business leans on the owner-operator, which raises patient-retention and continuity concerns for a buyer. If most of your revenue runs through you or one injector, expect a buyer to price that risk in the multiple or in the deal structure. Getting membership revenue, injector concentration and deferred revenue into a form a buyer accepts is what a med spa CFO does in the year before a sale, and the cost structure behind those margins is where the normalization starts.
Talk it through
Want Stan to look at this for your clinic?
Book a free 30-minute call with Stan Sukhinin, CFA. Bring the question and, if you have it, last month's P&L. He will tell you what he would check first.
Continue with Sorso
How clinic owners typically work with us after a question like this
Med Spa Accounting & CFO
Built for med spa economics
Injectable and device margins, membership revenue, and cash-pay mix — for med spa owners. From $2,000/mo.
Explore your specialty →Accounting
Healthcare-specialist accounting
Books done right by people who understand clinic finance. Starts at $2,000/mo.
Explore Accounting →Free Assessment
See where your clinic stands
4-minute, 15-question diagnostic. Personalized scorecard emailed to you.
Take the Free Assessment →Related questions
How much does it cost to start a med spa?
The most detailed public figure is $491,792 to $906,189 to open one med spa, from dermani MEDSPA's 2026 franchise disclosure, covering buildout, equipment, opening inventory and three months of operating funds. Sorso estimate: about $430,000 to $840,000 for an independent spa built to the same standard, after taking out the $55,000 franchise fee, the $5,000 training fee and $3,000 to $8,000 of training travel. Leasehold improvements ($124,257 to $309,376) and equipment ($117,062 to $194,300) are the two biggest lines.
What is a dermatology practice worth?
A dermatology practice typically sells for 3x to 5x EBITDA as a solo practice and 4x to 7x as a small group of one to four locations, according to Scope Research's 2026 dermatology update. Large and mid-sized groups with $15M to $50M of revenue reach 7x to 10x, and large integrated platforms 12x to 15x. Scope names in-house pathology, Mohs surgery and cosmetic services as things that can lift margins, but it puts no premium in turns on any of them.
How do PE firms value medical practices?
Private equity firms value a medical practice as a multiple of its trailing-twelve-month adjusted EBITDA, and the multiple rises with scale. Published ladders run from 2.5–4x for a single owner-operated physical therapy clinic (Breakwater M&A) to 10x–20x for large primary care platforms (Scope Research), and payer mix, growth and owner dependence move a practice within its band.
What is rollover equity in a practice sale?
Rollover equity is the portion of sale proceeds that the selling owner retains as equity in the buyer's platform, generally 10 to 40 percent of the practice's total enterprise value in physician deals according to Foley & Lardner, creating a second liquidity event when the platform is later sold.
How long does it take to sell a medical practice?
Selling a medical practice to a PE buyer usually takes about six to nine months from hiring an advisor to closing. FOCUS Investment Banking says its healthcare sell-side process typically takes 6 months, and broker Raincatcher puts a clinic or small-group sale at six to nine months: preparation and valuation in months one to two, marketing and offers in months two to five, and diligence, licensing and closing in months five to nine.
How does the revenue cycle work for a cash-only med spa with no insurance?
Cash-pay med spas skip the entire insurance billing stack, which means no claims, no denials, no insurance receivables, and no payer contracting. Revenue cycle work moves upstream into pricing, package design, deposit policies, financing partners (CareCredit, Cherry, Affirm), and chargeback management. There is almost no receivable to chase, since patients pay at checkout and CareCredit, for one, pays providers within two business days, so refund risk, deposit accounting, and sales tax compliance become the operational pressure points.
Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.
Want to see how your practice measures up?
Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.